Concepedia

Laurence Booth

LB

66

Publications

2.6K

Citations

33

H-Index

1993

Active since

Affiliations

Virginia Commonwealth University(Current)

University of Richmond

Puma Biotechnology (United States)

Translational Genomics Research Institute

The University of Texas Health Science Center at Houston

Laurence Booth is an author at Virginia Commonwealth University specializing in medicine, tumor biology, and pharmacology.

Top concepts

MedicineCell BiologyPharmacologyTumor BiologyCell DeathCell SignalingCancer ResearchCancer Cell BiologyImmunologyApoptosis

Publications per year

1993–2023

66

Publications

66

Lycopene and<i>β</i>-carotene protect against oxidative damage in HT29 cells at low concentrations but rapidly lose this capacity at higher doses

Gordon Lowe, Laurence Booth, Andrew Young et al. · Free Radical Research · 1999 · 208 citations

HDAC inhibitors enhance the immunotherapy response of melanoma cells

Laurence Booth, Jane L. Roberts, Andrew Poklepovic et al. · Oncotarget · 2017 · 132 citations · Full text

Hdac Inhibitors, Tumor Immunology, Melanoma Isolates +10

GRP78/BiP/HSPA5/Dna K is a universal therapeutic target for human disease

Laurence Booth, Jane L. Roberts, Devin R. Cash et al. · Journal of Cellular Physiology · 2014 · 97 citations · Full text

Grp78/bip/hspa5/dna K, Immunology, Human Polymorphism +16

Neratinib inhibits Hippo/YAP signaling, reduces mutant K-RAS expression, and kills pancreatic and blood cancer cells

Paul Dent, Laurence Booth, Jane L. Roberts et al. · Oncogene · 2019 · 85 citations · Full text

Tumor Biology, Blood Cancer Cells, Hippo/yap Signaling +11

Phosphodiesterase 5 Inhibitors Enhance Chemotherapy Killing in Gastrointestinal/Genitourinary Cancer Cells

Laurence Booth, Jane L. Roberts, Nichola Cruickshanks et al. · Molecular Pharmacology · 2013 · 71 citations · Full text

Rows per page

1–5 of 66